# Comparable Effects of Lanreotide Autogel and Octreotide LAR on GH, IGF-I Levels and Patient Satisfaction

> **NCT00145405** · PHASE4 · COMPLETED · sponsor: **Odense University Hospital** · enrollment: 12 (—)

## Conditions studied

- Acromegaly

## Interventions

- **DRUG:** Lanreotide Autogel and Octreotide LAR

## Key facts

- **NCT ID:** NCT00145405
- **Lead sponsor:** Odense University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-09
- **Primary completion:** —
- **Final completion:** 2004-12
- **Target enrollment:** 12 (—)
- **Last updated:** 2006-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00145405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00145405, "Comparable Effects of Lanreotide Autogel and Octreotide LAR on GH, IGF-I Levels and Patient Satisfaction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00145405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*